SenesTech stock weighs record Q2 revenue against a tiny base

Published on 10/07/2026 at 04:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 770,000, up 56 percent sequentially, on September 29. Gross margin hit 76.6 percent while SNES was last at USD 0.83.

SNES, US81720R6045, Illustration mit AI erstellt.

SenesTech stock (ISIN US81720R6045) was last at USD 0.83 on Nasdaq on October 6, 2026, while the company highlighted record second-quarter revenue of USD 770,000. The result gives the small specialty chemicals company a measurable growth marker, but its USD 4.4 million market capitalization shows how early the commercial reset remains.

Revenue reaches a new quarterly high

According to Investing.com on September 29, 2026, SenesTech said second-quarter revenue rose 56 percent from the prior quarter to USD 770,000. The company also reported a gross margin of 76.6 percent, its highest quarterly level, while net loss improved from USD 2.1 million in the first quarter to USD 1.8 million in the second quarter.

The finance figures point to operating leverage in the gross profit line: gross profit increased from USD 338,000 in Q1 2026 to USD 567,000 in Q2 2026. Operating loss also narrowed from USD 2.1 million to USD 1.9 million over the same period, although operating cash flow remained negative at USD 1.7 million in Q2 2026.

E-commerce becomes the growth engine

The September 29 presentation described a commercial model built around e-commerce, B2B sales, and services. Investing.com reported that e-commerce revenue nearly tripled sequentially, Amazon revenue rose more than fivefold, and subscription revenue nearly doubled during Q2 2026.

SenesTech also expanded distribution through Grove Collaborative. In a September 23, 2026 release, SenesTech said its Evolve products would become available through Grove's online marketplace. The move adds a third-party consumer channel to the direct Amazon and company website strategy.

Small valuation keeps execution central

SenesTech's latest market figures underline the scale of the challenge. The stock was last at USD 0.83 on Nasdaq on October 6, 2026, down USD 0.01, or 0.71 percent, from the prior session, with volume of 83,556 shares. Its 52-week range is USD 0.62 to USD 4.45.

The company is selling products designed to manage rodent populations through fertility control, including Evolve and ContraPest. The Q2 comparison is encouraging on revenue and margin, but the USD 1.7 million operating cash outflow means commercial growth must continue before the business can support itself through operations.

SNES remains a high risk small cap

SNES was last at USD 0.83 on Nasdaq on October 6, 2026 at 4:00 p.m. ET. The stock's USD 4.4 million market capitalization leaves quarterly execution, cash use and repeat customer growth as the central measures for evaluating the turnaround.